Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,200 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

NCT00101972

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +80 more
Locations
  • Premiere Oncology Santa Monica, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Safety Study of MGA271 in Refractory Cancer

NCT01391143

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +49 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors

NCT02966691

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Hôpital d'Antony Antony, France
  • Clinique " la Châtaigneraie " Beaumont, France
  • CHU de Besançon Besançon, France
  • CHU de Clermont-Ferrand Clermont-Ferrand, France
View all 14 locations
View Trial Details

Related conditions